Dermisonics Company Top Insiders

Dermisonics employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 22 years, averaging almost 11.0 years of service per executive, having 1.0 employees per reported executive. Assessment of Dermisonics' management performance can provide insight into the firm performance.
Bruce Haglund  Chairman
Chairman of the Board, Interim CEO, Interim CFO
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermisonics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For more detail on how to invest in Dermisonics Stock please use our How to Invest in Dermisonics guide.

Dermisonics Management Team Effectiveness

The company has return on total asset (ROA) of (0.1206) % which means that it has lost $0.1206 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.9224) %, meaning that it created substantial loss on money invested by shareholders. Dermisonics' management efficiency ratios could be used to measure how well Dermisonics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -7.69. The current Return On Capital Employed is estimated to decrease to -0.26. The Dermisonics' current Other Current Assets is estimated to increase to about 491.4 K, while Total Assets are projected to decrease to under 16.4 M.
The current Net Loss is estimated to decrease to about (4.8 M)
Some institutional investors establish a significant position in stocks such as Dermisonics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Dermisonics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Dermisonics Workforce Comparison

Dermisonics is currently under evaluation in number of employees category among its peers. The total workforce of Medical Devices industry is currently estimated at about 247. Dermisonics adds roughly 0.0 in number of employees claiming only tiny portion of all equities under Medical Devices industry.

Dermisonics Benchmark Summation

Operator
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was zero with a total number of output elements of sixty-one. Dermisonics Price Series Summation is a cross summation of Dermisonics price series and its benchmark/peer.

Dermisonics Notable Stakeholders

A Dermisonics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Dermisonics often face trade-offs trying to please all of them. Dermisonics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Dermisonics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
JD EsqActing ChairmanProfile
Bruce HaglundChairman of the Board, Interim CEO, Interim CFOProfile
String symbol = request.getParameter("s");

About Dermisonics Management Performance

The success or failure of an entity such as Dermisonics often depends on how effective the management is. Dermisonics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Dermisonics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Dermisonics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(7.32)(7.69)
Return On Capital Employed(0.25)(0.26)
Return On Assets(0.23)(0.24)
Return On Equity(0.29)(0.31)

Dermisonics Workforce Analysis

Traditionally, organizations such as Dermisonics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Dermisonics within its industry.

Dermisonics Manpower Efficiency

Return on Dermisonics Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2.5M
Net Loss Per Executive2.5M

Complementary Tools for Dermisonics Stock analysis

When running Dermisonics' price analysis, check to measure Dermisonics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermisonics is operating at the current time. Most of Dermisonics' value examination focuses on studying past and present price action to predict the probability of Dermisonics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermisonics' price. Additionally, you may evaluate how the addition of Dermisonics to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance